Research — APO Research, Inc.

Pharma & Healthcare

Perphenazine

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.

Types: Oral Forms · Injectable Solution
Applications: Psychosis · Antiemetic

5 editions9 January 2026

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: Perphenazine Compare research options for Perphenazine

Pharma & Healthcare

Fusion Protein VEGF Inhibitor

Types: Conbercept · Aflibercept · Other
Applications: Degenerative Eye Diseases · Cancer · Other

5 editions27 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: Fusion Protein VEGF Inhibitor Compare research options for Fusion Protein VEGF Inhibitor

Pharma & Healthcare

Anthrax Vaccines

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

Types: Live Vaccines · Cell free PA Vaccines
Applications: Human Use · Animal Use

5 editions1 January 2026

View 5 research editions

$2,950Single user · USD · Industry ResearchExplore product: Anthrax Vaccines Compare research options for Anthrax Vaccines

Pharma & Healthcare

Empty Capsule

Types: Gelatin · Non-Gelatin
Applications: Pharmaceutical · Others · Nutraceutical

5 editions20 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: Empty Capsule Compare research options for Empty Capsule

Pharma & Healthcare

Phenylketonuria Treatment

Types: Medications · Supplements
Applications: Household · Hospital

5 editions2 January 2026

View 5 research editions

$3,950Single user · USD · Market StructureExplore product: Phenylketonuria Treatment Compare research options for Phenylketonuria Treatment

Pharma & Healthcare

Phosphoinositide 3-Kinase (PI3K) Inhibitors

Types: CLL - Chronic Iymphocytic Ieukemia · FL - Follicular Iymphoma · Other Indications
Applications: Clinic · hospital · Research Institutes and Research Institutions

5 editions22 December 2025

View 5 research editions